Nodus Oncology
UK-based biotech company focused on developing molecules that inhibit novel DNA damage response (DDR) targets
Edinburgh, UKwww.nodusoncology.com ↗
Total raised
€2.7M
€2,693,585
Funding rounds
1
Investors
2
distinct backers
Active since
2023-02
latest 2023-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood22
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-02-07 | Other | €2.7M | Cumulus Oncology,KHAN Technology Transfer Fund I | View deal → |
Related news
- Nodus Oncology Raises £2.4M in Fundingfinsmes.com · 2023-02